SavedAdd your journal

Journals / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 2

Comparison of Seventh and Eighth Editions of TNM Staging Classification and Evaluation of Survivals in Operated Non-Small Cell Lung Carcinomas: Single Center Experience

Tunç LAÇİN
Perran Fulden YUMUK
Özlem ERCELEP
Faysal DANE
Özkan ALAN
Tuğba A. TELLİ
Tuğba B. TÜYLÜ
Rukiye ARIKAN
Nazım Can DEMİRCAN
Derya KOCAKAYA
Emine BOZKURTLAR
Pages
243–246
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presence of surgical margin positivity, lymphatic, perineural and vascular invasion were poorprognostic factors (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, our purpose was to compare the survivals of the 7th and 8th editions of TNM staging system innon-small cell lung cancer (NSCLC).Methods: We retrospectively compared pathological staging and survival of 209 patients who were operated with thediagnosis of NSCLC between 2006 and 2017.
📊
Key Findings & Data:In this study, we did not include metastatic patients, patients receivingpreoperative treatment, patients with low grade malignancy and patients with neuroendocrine carcinoma.Results: Three of the 31 stage 1A changed to 1A1, 11 to 1A2, 17 to 1A3; 16 of the 40 stage 1B changed to 2A; 2 of the38 stage 2B changed to 1B, 21 changed to 3A; 2 of the 41 stage 3A changed to 2B, 7 changed to 3B.
💡
Conclusion & Impact:Presence of surgical margin positivity, lymphatic, perineural and vascular invasion were poorprognostic factors (p
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, our purpose was to compare the survivals of the 7th and 8th editions of TNM staging system innon-small cell lung cancer (NSCLC).Methods: We retrospectively compared pathological staging and survival of 209 patients who were operated with thediagnosis of NSCLC between 2006 and 2017. In this study, we did not include metastatic patients, patients receivingpreoperative treatment, patients with low grade malignancy and patients with neuroendocrine carcinoma.Results: Three of the 31 stage 1A changed to 1A1, 11 to 1A2, 17 to 1A3; 16 of the 40 stage 1B changed to 2A; 2 of the38 stage 2B changed to 1B, 21 changed to 3A; 2 of the 41 stage 3A changed to 2B, 7 changed to 3B. When we groupedstages as I, II, III; there was a significant difference in prognostic effects between 7th edition stages (p=0.01) and 8thedition stages (p=0.02). Presence of surgical margin positivity, lymphatic, perineural and vascular invasion were poorprognostic factors (p

🔖

Cite This Article

LAÇİN, T., YUMUK, P. F., ERCELEP, Ö., DANE, F., ALAN, Ö., TELLİ, T. A., TÜYLÜ, T. B., ARIKAN, R., DEMİRCAN, N. C., KOCAKAYA, D., BOZKURTLAR, E. (2022). Comparison of Seventh and Eighth Editions of TNM Staging Classification and Evaluation of Survivals in Operated Non-Small Cell Lung Carcinomas: Single Center Experience. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 2, 243–246. https://ajindex.com/articles/508655

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Didkowska J, Wojciechowska U, Manczuk M, Lobaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med 2016
  2. [CrossRef ] 2. Mitsudomi T. Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations. Transl Lung Cancer Res 2014
  3. 205–11. 3. Lv Y, Jin Y, Xu D, Yan Q, Liu G, Zhang H, Yuan D, Bao J. Assessment of 64-slice spiral computed tomography with perfusion weighted imaging in the early diagnosis of ground-glass opacity lung cancer. J BUON 2016
  4. Tsim S, O'Dowd CA, Milroy R, Davidson S. Staging of non-small cell lung cancer (NSCLC): a review. Respir Med 2010
  5. 1767– 74. [CrossRef ] 5. Detterbeck FC. The eighth edition TNM stage classification for lung cancer: What does it mean on main street? J Thorac Cardiovasc Surg 2018
  6. 356–359. [CrossRef ] 6. Asamura H, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging project: proposals for the revision of the N descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2015
  7. 1675–1684. [CrossRef ] 7. Eberhardt W, Mitchell J, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the M descriptors in the forthcoming (8th) edition of the TNM classification of lung cancer. J ThoracOncol 2015
  8. 1515–1522. 8. Nicholson A, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TMN classification for lung cancer. J Thorac Oncol 2016
  9. 300–311. [CrossRef ] 9. Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2015
  10. 990–1003. 10. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2015
  11. 39–51. [CrossRef] 11. Rami-Porta R, Bolejack V, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014
  12. 1618–1624. [CrossRef ] 12. K. Chansky, F. C. Detterbeck, A. G. Nicholson, V. W. Rusch, E. Vallieres, P. Groome et al. The IASLC Lung Cancer Stag